Jc. Cate et N. Reilly, Evaluation and implementation of the gel test for indirect antiglobulin testing in a community hospital laboratory, ARCH PATH L, 123(8), 1999, pp. 693-697
Citations number
24
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Background.-The gel test, developed by Lapierre in 1984, was designed to st
andardize antiglobulin testing while improving sensitivity and specificity
of the method.
Principle.-Anti-human serum immunoglobulin C (IgG) mixed with Sephadex G100
(gel phase) in a microtube traps red cell-IgG agglutination complexes duri
ng migration through the gel in a centrifugation step. Agglutination comple
xes are visibly detectable at various levels in the microtube as an inverse
function of antibody coated on red cells. Unsensitized red cells form a ce
ll pellet at the base of the microtube.
Objective.-To determine if indirect anti-human globulin testing could be st
andardized and simplified by replating the tube test with the gel test with
out compromising quality or increasing costs.
Setting.-A medium-sized community hospital.
Results.-In a blinded retrospective study, we used pa tient sera (n = 40),
which included 10 positive specimens containing 18 known antibodies. Sixtee
n antibodies were detected and identified with the tube method (1 anti-D an
d 1 anti-C not detected). By the gel test, 18 antibodies were detected and
identified. All negative samples showed 100% concordance. Favorable results
were obtained in a nonblinded prospective correlation study (n = 121). Our
technologists found the gel test easier to read and more reproducible and
reliable than the tube method; they also found increased sensitivity for de
tecting weakly reading antibodies. We successfully introduced the gel test
into our laboratory as the standard method for indirect antiglobulin testin
g. Following implementation, improved personnel management was achieved.
Conclusions.-The gel test is a reliable and advantageous method and is appr
opriate for routine use for detection and identification of alloantibodies
in a community hospital transfusion service laboratory.